Alterity Therapeutics to Present at MST Access Webinar on June 12, 2024

June 12, 2024 -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE), a biotechnology company focused on developing treatments for neurodegenerative diseases, announced today that its Chief Executive Officer, David Stamler, M.D., will present a company overview at the MST Access ‘Hidden Gems in Life Sciences’ webinar. The presentation is scheduled for Thursday, June 13, 2024, in Australia, and Wednesday, June 12, 2024, in the United States.

Details for the webcast are as follows:

For Australian participants:
- Date: Thursday, June 13, 2024
- Time: 1:30 p.m. AEST (Sydney/Melbourne)

For U.S. participants:
- Date: Wednesday, June 12, 2024
- Time: 8:30 p.m. Pacific Time / 11:30 p.m. Eastern Time

Participants can join the presentation by clicking the webinar link provided in the announcement. During the call, investors will have the opportunity to ask questions following the presentation. Additionally, a recording of the webinar will be available on the Alterity Therapeutics website after the event.

About Alterity Therapeutics

Alterity Therapeutics is a clinical-stage biotechnology company committed to developing transformative treatments for individuals affected by neurodegenerative diseases. The company's lead product candidate, ATH434, is being investigated for its potential to treat Parkinsonian disorders and is currently undergoing two Phase 2 clinical trials targeting Multiple System Atrophy. In addition to ATH434, Alterity has established a comprehensive drug discovery platform aimed at generating novel chemical compounds that address the fundamental causes of neurological diseases. The company operates out of Melbourne, Australia, and San Francisco, California, USA.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!